Pages that link to "Q38868844"
Jump to navigation
Jump to search
The following pages link to Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1. (Q38868844):
Displaying 27 items.
- NEMO stabilizes c‐Myc through direct interaction in the nucleus (Q24304306) (← links)
- Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis (Q33787273) (← links)
- MYC cofactors: molecular switches controlling diverse biological outcomes (Q34083178) (← links)
- Activation of JNK contributes to evodiamine-induced apoptosis and G2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine (Q35193849) (← links)
- Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget (Q35273449) (← links)
- MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition (Q35894198) (← links)
- CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression (Q37229083) (← links)
- Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity (Q37313139) (← links)
- Differential regulation of N-Myc and c-Myc synthesis, degradation, and transcriptional activity by the Ras/mitogen-activated protein kinase pathway (Q38928485) (← links)
- Cdk5 links with DNA damage response and cancer (Q39176295) (← links)
- MYC Modulation around the CDK2/p27/SKP2 Axis (Q39406924) (← links)
- PIM1: a promising target in patients with triple-negative breast cancer. (Q39443294) (← links)
- Cyclin G2 regulates adipogenesis through PPAR gamma coactivation (Q39655608) (← links)
- Elucidating the rapid action of 2-(2-chlorophenyl)ethylbiguanide on HT-29 cells under a serum- and glucose-deprived condition (Q47717403) (← links)
- Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression (Q50031768) (← links)
- c-Myc regulates the CDK1/cyclin B1 dependent‑G2/M cell cycle progression by histone H4 acetylation in Raji cells. (Q52670068) (← links)
- The MYC oncogene is a global regulator of the immune response. (Q52728139) (← links)
- Placenta-specific 9, a putative secretory protein, induces G2/M arrest and inhibits the proliferation of human embryonic hepatic cells (Q57021092) (← links)
- Exploiting Oncogenic Drivers along the Pathway for Cancer Therapy and Gene Therapy (Q60303014) (← links)
- RETRACTED ARTICLE: 67-kDa laminin receptor induces FasL expression and FasL-mediated apoptosis through the activation of c-Myc and the subsequent activation of the FasL promoter in human cholangiocarcinoma cells (Q82897827) (← links)
- USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer (Q85682295) (← links)
- IGH rearrangement in myeloid neoplasms (Q90280720) (← links)
- LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5 (Q92295991) (← links)
- Atypical cyclins: the extended family portrait (Q92669414) (← links)
- CDK5 neutralizes the tumor suppressing effect of BIN1 via mediating phosphorylation of c-MYC at Ser-62 site in NSCLC (Q93185953) (← links)
- Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad (Q96225135) (← links)
- Altering MYC phosphorylation in the epidermis increases the stem cell population and contributes to the development, progression, and metastasis of squamous cell carcinoma (Q99207464) (← links)